Jefferies Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Jefferies Group’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-109,672	Closed	-$4.52M	–	3696
2015 Q2	$4.52M	Buy	109,672 +109,572	+109,572%	+$3.93M	0.02%	559
2015 Q1	$4K	Buy	+100	New	+$3.38K	﹤0.01%	2014
2014 Q4	–	Sell	-63	Closed	-$1.82K	–	2615
2014 Q3	$2K	Sell	63 -26,442	-100%	-$805K	﹤0.01%	2090
2014 Q2	$801K	Buy	26,505 +22,405	+546%	+$618K	0.01%	1007
2014 Q1	$113K	Buy	+4,100	New	+$107K	﹤0.01%	1822

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Jefferies Group's BRLI Position: Q3 2015 in Review

Jefferies Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 109,672 shares — an estimated $4.52M sold.

Jefferies Group first reported a position in BRLI in Q1 2014 and held it in 5 quarters. The position peaked at $4.52M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Jefferies Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Jefferies Group sold 109,672 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $4.52M.
Jefferies Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q1 2014 and held it in 5 quarters.
Jefferies Group's BIO-REFERENCE LABS INC-NEW- position peaked at $4.52M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Jefferies Group's 13F filing for Q3 2015, filed 13 Nov 2015.